2006 Publications

Publications resulting from human brain tissue obtained from the ABBN.

Alexander-Kaufman K, James G, Sheedy D, Harper C, and Matsumoto I. (2006) Differential protein expression in the prefrontal white matter of human alcoholics: a proteomics study. Mol Psychiatr. 11: 56-65.

Al-Housseini AM, Dodd PR, Gu Q, Lewohl JM, Mayfield RD, and Harris RA. (2006) Upregulation of β-catenin protein in superior frontal cortex of chronic alcoholics. Alcohol Clin Exp Res. 30: 218A-218A.

Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ, Barbour R, Huang J, Kling K, Lee M, Diep L, Keim PS, Shen X, Chataway T, Schlossmacher MG, Seubert P, Schenk D, Sinha S, Gai WP, and Chilcote TJ. (2006) Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease. The Journal of biological chemistry. 281: 29739-29752.

Azizi L, Garrick TM, and Harper CG. (2006) Brain donation for research: strong support in Australia. J Clin Neurosci. 13: 449-452.

Baker KG, Huang Y, McCann H, Gai WP, Jensen PH, and Halliday GM. (2006) P25α immunoreactive but α-synuclein immunonegative neuronal inclusions in multiple system atrophy. Acta neuropathologica. 111: 193-195.

Blair IP, Chetcuti AF, Badenhop RF, Scimone A, Moses MJ, Adams LJ, Craddock N, Green E, Kirov G, Owen MJ, Kwok JB, Donald JA, Mitchell PB, and Schofield PR. (2006) Positional cloning, association analysis and expression studies provide convergent evidence that the cadherin gene FAT contains a bipolar disorder susceptibility allele. Mol Psychiatr. 11: 372-383.

Bowden NA, Weidenhofer J, Scott RJ, Schall U, Todd J, Michie PT, and Tooney PA. (2006) Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia. Schizophr Res. 82: 175-183.

Chen T, Ajami K, McCaughan GW, Gai WP, Gorrell MD, and Abbott CA. (2006) Molecular characterization of a novel dipeptidyl peptidase like 2-short form (DPL2-s) that is highly expressed in the brain and lacks dipeptidyl peptidase activity. Biochim Biophys Acta. 1764: 33-43.

Dean B, Pavey G, Thomas D, and Scarr E. (2006) Cortical serotonin7, 1D and 1F receptors: effects of schizophrenia, suicide and antipsychotic drug treatment. Schizophr Res. 88: 265-274.

Dean B, Gray L, and Scarr E. (2006) Regionally specific changes in levels of cortical S100β in bipolar 1 disorder but not schizophrenia. Aust N Z J Psychiatry. 40: 217-224.

Dean B, Beneyto M, Meador-Woodruff J, McCullumsmith R, and Scarr E. (2006) Reply: Autoradiography of 3H aspartate and glutamate transport in chizophrenia. Neuropsychopharmacology. 31: 687-688.

Deng C, and Huang XF. (2006) Increased density of GABAA receptors in the superior temporal gyrus in schizophrenia. Exp Brain Res. 168: 587-590.

Dodd PR, Buckley ST, Foley PF, Eckert AL, and Innes DJ. (2006) Genes and gene expression in human alcoholic brain. Alcohol Clin Exp Res. 30: 218A-218A.

Duce JA, Smith DP, Blake RE, Crouch PJ, Li QX, Masters CL, and Trounce IA. (2006) Linker histone H1 binds to disease associated amyloid-like fibrils. J Mol Biol. 361: 493-505.

Fedorow H, Halliday GM, Rickert CH, Gerlach M, Riederer P, and Double KL. (2006) Evidence for specific phases in the development of human neuromelanin. Neurobiol Aging. 27: 506-512.

Flatscher-Bader T, van der Brug MP, Landis N, Hwang JW, Harrison E, and Wilce PA. (2006) Comparative gene expression in brain regions of human alcoholics. Genes Brain Behav. 5 Suppl 1: 78-84.

Flatscher-Bader T, and Wilce PA. (2006) Chronic smoking and alcoholism change expression of selective genes in the human prefrontal cortex. Alcohol Clin Exp Res. 30: 908-915.

Garrick T, Howell S, Terwee P, Redenbach J, Blake H, and Harper C. (2006) Brain donation for research: who donates and why? J Clin Neurosci. 13: 524-528.

Garrick T, Glaw X, Harper CG, and North A. (2006) The diagnosis is critical for psychiatric brain banks: an interrater reliability study. Aust N Z J Psychiatry. 40: 606-607.

Gray L, Scarr E, and Dean B. (2006) Serotonin 1a receptor and associated G-protein activation in schizophrenia and bipolar disorder. Psychiatry Res. 143: 111-120.

Gray L, Scarr E, and Dean B. (2006) N-Ethylmaleimide sensitive factor in the cortex of subjects with schizophrenia and bipolar I disorder. Neurosci Lett. 391: 112-115.

Halliday GM, Fedorow H, Rickert CH, Gerlach M, Riederer P, and Double KL. (2006) Evidence for specific phases in the development of human neuromelanin. J Neural Transm. 113: 721-728.

Harper C. (2006) Thiamine (vitamin B1) deficiency and associated brain damage is still common throughout the world and prevention is simple and safe! Eur J Neuro. 13: 1078-1082.

Ide M, Ohnishi T, Murayama M, Matsumoto I, Yamada K, Iwayama Y, Dedova I, Toyota T, Asada T, Takashima A, and Yoshikawa T. (2006) Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia. J Neurochem. 99: 277-287.

Kapoor R, Lim KS, Cheng A, Garrick T, and Kapoor V. (2006) Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, D-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1). Brain research. 1106: 205-210.

Kozlovsky N, Scarr E, Dean B, and Agam G. (2006) Postmortem brain calcineurin protein levels in schizophrenia patients are not different from controls. Schizophr Res. 83: 173-177.

Kuo SW, and Dodd PR. (2006) Electrically-evoked neurotransmitter release in relation to alcoholism. J Neurochem. 98: 34-34.

Liu J, Lewohl JM, Harris RA, Iyer VR, Dodd PR, Randall PK, and Mayfield RD. (2006) Patterns of gene expression in the frontal cortex discriminate alcoholic from nonalcoholic individuals. Neuropsychopharmacology. 31: 1574-1582.

Masters CL, Cappai R, Barnham KJ, and Villemagne VL. (2006) Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics. J Neurochem. 97: 1700-1725.

Nakatani N, Hattori E, Ohnishi T, Dean B, Iwayama Y, Matsumoto I, Kato T, Osumi N, Higuchi T, Niwa S, and Yoshikawa T. (2006) Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Hum Mol Genet. 15: 1949-1962.

Newell KA, Deng C, and Huang XF. (2006) Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. Exp Brain Res. 172: 556-560.

Perry A, Dodd PR, and Worrall S. (2006) Detection of elevated protein modification in human cerebellum in alcoholic cerebellar degeneration. Alcohol Clin Exp Res. 30: 218A-218A.

Quilty MC, King AE, Gai WP, Pountney DL, West AK, Vickers JC, and Dickson TC.. (2006) α-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection. Exp Neurol. 199: 249-256.

Rodda KE, Dean B, McIntyre IM, and Drummer OH. (2006) Brain distribution of selected antipsychotics in schizophrenia. Forensic Sci Int. 157: 121-130.

Scarr E, Keriakous D, Crossland N, and Dean B. (2006) No change in cortical muscarinic M2, M3 receptors or [35S]GTPγS binding in schizophrenia. Life Sci. 78: 1231-1237.

Scarr E, Gray L, Keriakous D, Robinson PJ, and Dean B. (2006) Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder. Bipolar Disord. 8: 133-143.

Tannenberg RK, Scott HL, Tannenberg AE, and Dodd PR. (2006) Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE ε4. Neurochem Int. 49: 631-639.

Walton HS, Innes DJ, Gebhardt FM, and Dodd PR. (2006) Real-time quantitative RT-PCR analysis of EAAT2 splice variants. J Neurochem. 96: 25-25.

Weidenhofer J, Bowden NA, Scott RJ, and Tooney PA. (2006) Altered gene expression in the amygdala in schizophrenia: up-regulation of genes located in the cytomatrix active zone. Mol Cell Neurosci. 31: 243-250.

Weidenhofer J, Yip J, Zavitsanou K, Huang XF, Chahl LA, and Tooney PA. (2006) Immunohistochemical localisation of the NK1 receptor in the human amygdala: preliminary investigation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 30: 1313-1321.

Wheeler DG, Dixon G, and Harper CG. (2006) No differences in calcium-binding protein immunoreactivity in the posterior cingulate and visual cortex: schizophrenia and controls. Prog Neuropsychopharmacol Biol Psychiatry. 30: 630-639.

Woodhouse A, Dickson TC, West AK, McLean CA, and Vickers JC. No difference in expression of apoptosis-related proteins and apoptotic morphology in control, pathologically aged and Alzheimer's disease cases. Neurobiol Dis. 22: 323-333.

Woodhouse A, Vickers JC, and Dickson TC. (2006) Cytoplasmic cytochrome c immunolabelling in dystrophic neurites in Alzheimer's disease. Acta neuropathologica. 112: 429-437.

Yan M, Cooper W, Harper C, and Schwartz R. (2006) Dementia in a patient with non-paraneoplastic limbic encephalitis associated with relapsing polychondritis. Pathology. 38: 596-599.